Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease

BACKGROUND: SLE manifestations after ESRD may be underdiagnosed and undertreated, contributing to increased morbidity and mortality. Whether specific symptoms persist after ESRD or a shift towards new manifestations occurs has not been extensively studied, especially in the non-Caucasian patients in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Nephrol
Main Authors: Salgado Guerrero, Maria, Londono Jimenez, Alejandra, Dobrowolski, Chrisanna, Mowrey, Wenzhu B., Goilav, Beatrice, Wang, Shudan, Broder, Anna
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7592532/
https://ncbi.nlm.nih.gov/pubmed/33115441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-02083-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados